Ocular Therapeutix Inc

XNAS:OCUL 1:00:00 PM EDT

12.71

-0.03 (-0.24%)

4:40:48 PM EDT: $12.59 -0.12 (-0.94%)

Market Cap (Intraday)	2.71B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$16.13 Million
Adjusted EPS	-$0.32

See more estimates

10-Day MA	$13.14
50-Day MA	$12.28
200-Day MA	$10.43

See more pivots

Ocular Therapeutix Inc Stock, XNAS:OCUL

15 Crosby Drive, 15 Crosby Drive, Bedford, Massachusetts 01730

United States of America

Phone: +1.781.357.4000

Number of Employees: 274

http://www.ocutx.com

Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.